These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 38970095

  • 1. Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patients.
    Hovorkova L, Winkowska L, Skorepova J, Krumbholz M, Benesova A, Polivkova V, Alten J, Bardini M, Meyer C, Kim R, Trahair TN, Clappier E, Chiaretti S, Henderson M, Sutton R, Sramkova L, Stary J, Polakova KM, Marschalek R, Metzler M, Cazzaniga G, Cario G, Trka J, Zaliova M, Zuna J.
    Mol Cancer; 2024 Jul 05; 23(1):138. PubMed ID: 38970095
    [Abstract] [Full Text] [Related]

  • 2. Fine structure of translocation breakpoints within the major breakpoint region in BCR-ABL1-positive leukemias.
    Burmeister T, Gröger D, Kühn A, Hoelzer D, Thiel E, Reinhardt R.
    DNA Repair (Amst); 2011 Nov 10; 10(11):1131-7. PubMed ID: 21944569
    [Abstract] [Full Text] [Related]

  • 3. Analysis of genomic breakpoints in p190 and p210 BCR-ABL indicate distinct mechanisms of formation.
    Score J, Calasanz MJ, Ottman O, Pane F, Yeh RF, Sobrinho-Simões MA, Kreil S, Ward D, Hidalgo-Curtis C, Melo JV, Wiemels J, Nadel B, Cross NC, Grand FH.
    Leukemia; 2010 Oct 10; 24(10):1742-50. PubMed ID: 20703256
    [Abstract] [Full Text] [Related]

  • 4. Genomic BCR-ABL1 breakpoints in pediatric chronic myeloid leukemia.
    Krumbholz M, Karl M, Tauer JT, Thiede C, Rascher W, Suttorp M, Metzler M.
    Genes Chromosomes Cancer; 2012 Nov 10; 51(11):1045-53. PubMed ID: 22887688
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Monitoring of childhood ALL using BCR-ABL1 genomic breakpoints identifies a subgroup with CML-like biology.
    Hovorkova L, Zaliova M, Venn NC, Bleckmann K, Trkova M, Potuckova E, Vaskova M, Linhartova J, Machova Polakova K, Fronkova E, Muskovic W, Giles JE, Shaw PJ, Cario G, Sutton R, Stary J, Trka J, Zuna J.
    Blood; 2017 May 18; 129(20):2771-2781. PubMed ID: 28331056
    [Abstract] [Full Text] [Related]

  • 7. p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias.
    van Rhee F, Hochhaus A, Lin F, Melo JV, Goldman JM, Cross NC.
    Blood; 1996 Jun 15; 87(12):5213-7. PubMed ID: 8652835
    [Abstract] [Full Text] [Related]

  • 8. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.
    Mullighan CG, Miller CB, Radtke I, Phillips LA, Dalton J, Ma J, White D, Hughes TP, Le Beau MM, Pui CH, Relling MV, Shurtleff SA, Downing JR.
    Nature; 2008 May 01; 453(7191):110-4. PubMed ID: 18408710
    [Abstract] [Full Text] [Related]

  • 9. Heterogeneous BCR-ABL1 signal patterns identified by fluorescence in situ hybridization are associated with leukemic clonal evolution and poorer prognosis in BCR-ABL1 positive leukemia.
    Zhang Z, Chen Z, Jiang M, Liu S, Guo Y, Wan L, Li F.
    BMC Cancer; 2019 Oct 08; 19(1):935. PubMed ID: 31594548
    [Abstract] [Full Text] [Related]

  • 10. Pre-B acute lymphoblastic leukemia with b3a2 (p210) and e1a2 (p190) BCR-ABL fusion transcripts relapsing as chronic myelogenous leukemia with a less differentiated b3a2 (p210) clone.
    Winter SS, Greene JM, McConnell TS, Willman CL.
    Leukemia; 1999 Dec 08; 13(12):2007-11. PubMed ID: 10602422
    [Abstract] [Full Text] [Related]

  • 11. RAG enhances BCR-ABL1-positive leukemic cell growth through its endonuclease activity in vitro and in vivo.
    Yuan M, Wang Y, Qin M, Zhao X, Chen X, Li D, Miao Y, Otieno Odhiambo W, Liu H, Ma Y, Ji Y.
    Cancer Sci; 2021 Jul 08; 112(7):2679-2691. PubMed ID: 33949040
    [Abstract] [Full Text] [Related]

  • 12. The Philadelphia chromosome in leukemogenesis.
    Kang ZJ, Liu YF, Xu LZ, Long ZJ, Huang D, Yang Y, Liu B, Feng JX, Pan YJ, Yan JS, Liu Q.
    Chin J Cancer; 2016 May 27; 35():48. PubMed ID: 27233483
    [Abstract] [Full Text] [Related]

  • 13. Clinical significance of BCR-ABL fusion gene subtypes in chronic myelogenous and acute lymphoblastic leukemias.
    Ye YX, Zhou J, Zhou YH, Zhou Y, Song XB, Wang J, Lin L, Ying BW, Lu XJ.
    Asian Pac J Cancer Prev; 2014 May 27; 15(22):9961-6. PubMed ID: 25520136
    [Abstract] [Full Text] [Related]

  • 14. Frequency of rare BCR-ABL1 fusion transcripts in chronic myeloid leukemia patients.
    Arun AK, Senthamizhselvi A, Mani S, Vinodhini K, Janet NB, Lakshmi KM, Abraham A, George B, Srivastava A, Srivastava VM, Mathews V, Balasubramanian P.
    Int J Lab Hematol; 2017 Jun 27; 39(3):235-242. PubMed ID: 28035733
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Non random distribution of genomic features in breakpoint regions involved in chronic myeloid leukemia cases with variant t(9;22) or additional chromosomal rearrangements.
    Albano F, Anelli L, Zagaria A, Coccaro N, Casieri P, Rossi AR, Vicari L, Liso V, Rocchi M, Specchia G.
    Mol Cancer; 2010 May 25; 9():120. PubMed ID: 20500819
    [Abstract] [Full Text] [Related]

  • 17. Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets.
    Adnan-Awad S, Kim D, Hohtari H, Javarappa KK, Brandstoetter T, Mayer I, Potdar S, Heckman CA, Kytölä S, Porkka K, Doma E, Sexl V, Kankainen M, Mustjoki S.
    Leukemia; 2021 Jul 25; 35(7):1964-1975. PubMed ID: 33168949
    [Abstract] [Full Text] [Related]

  • 18. Unusual expression of mRNA typical of Philadelphia positive acute lymphoblastic leukemia detected in chronic myeloid leukemia.
    Kirk JA, Radich J, Edmands S, Lee A, VanDevanter DR, Reems JA, Bryant EM.
    Am J Hematol; 1996 Jul 25; 52(3):129-34. PubMed ID: 8756076
    [Abstract] [Full Text] [Related]

  • 19. Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease.
    Zuna J, Hovorkova L, Krotka J, Koehrmann A, Bardini M, Winkowska L, Fronkova E, Alten J, Koehler R, Eckert C, Brizzolara L, Trkova M, Stuchly J, Zimmermann M, De Lorenzo P, Valsecchi MG, Conter V, Stary J, Schrappe M, Biondi A, Trka J, Zaliova M, Cazzaniga G, Cario G.
    Leukemia; 2022 Dec 25; 36(12):2793-2801. PubMed ID: 35933523
    [Abstract] [Full Text] [Related]

  • 20. Characterization of 46 patient-specific BCR-ABL1 fusions and detection of SNPs upstream and downstream the breakpoints in chronic myeloid leukemia using next generation sequencing.
    Linhartova J, Hovorkova L, Soverini S, Benesova A, Jaruskova M, Klamova H, Zuna J, Machova Polakova K.
    Mol Cancer; 2015 Apr 18; 14():89. PubMed ID: 25928096
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.